[对比增强超声：肝脏影像报告和数据系统（CEUS LI-RADS）]
[Contrast-enhanced ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS)].
作者信息
Dietrich Christoph F, Potthoff Andrej, Helmberger Thomas, Ignee Andre, Willmann Juergen K
机构信息
Department of Internal Medicine 2, Caritas-Krankenhaus Bad Mergentheim, Germany.
Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany.
出版信息
Z Gastroenterol. 2018 May;56(5):499-506. doi: 10.1055/s-0043-124874. Epub 2018 May 7.
The American College of Radiology (ACR) endorsed the Liver Imaging Reporting and Data System (LI-RADS) for standardized reporting and data collection of computed tomography (CT) and magnetic resonance (MR) imaging for hepatocellular carcinoma (HCC) in high-risk patients (liver cirrhosis). The LI-RADS imaging criteria are used to classify 'observations' from 'definitely benign' (LR-1) to 'definitely HCC' (LR-5) based on imaging criteria.Coincidently, the recent approval in the United States of a microbubble contrast agent for liver imaging (Lumason, known as SonoVue in Europe and elsewhere), LI-RADS. is being expanded to include contrast-enhanced ultrasound (CEUS). An international working group was initiated in 2014. Herewith, the most current version of CEUS-LI-RADS is presented.
美国放射学会（ACR）认可了肝脏影像报告和数据系统（LI-RADS），用于对高危患者（肝硬化）肝细胞癌（HCC）的计算机断层扫描（CT）和磁共振（MR）成像进行标准化报告和数据收集。LI-RADS成像标准用于根据成像标准将“观察结果”从“肯定良性”（LR-1）分类到“肯定为HCC”（LR-5）。巧合的是，美国最近批准了一种用于肝脏成像的微泡造影剂（Lumason，在欧洲和其他地区称为SonoVue），LI-RADS正在扩展到包括超声造影（CEUS）。一个国际工作组于2014年启动。在此，展示了CEUS-LI-RADS的最新版本。
Zotero 插件